Survival Benefit of Surgical Treatment for Elderly Patients with Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study in the SEER Database by Propensity Score Matching Analysis

Despite a rising trend in intrahepatic cholangiocarcinoma (ICC) incidence in the elderly population worldwide, the benefit of surgery for those patients is still controversial. Data from 811 elderly patients diagnosed with non-metastatic ICC were obtained from the US surveillance, epidemiology, and end results (SEER) program database. Propensity score matched (PSM) was conducted for the better balance of baseline. The associations between tumor characteristics and surgery with overall survival (OS) and cancer specific survival (CSS) were estimated using hazard ratios (HR) and 95% confidence intervals (CI). The results showed that ICC patients above 60 years old taking surgery had better OS (hazard ratio [HR], 0.258; 95% CI, 0.205–0.324) and CSS (hazard ratio [HR], 0.239; 95% CI, 0.188–0.303) than patients without surgery. Similar trends in patients above 65 years old, above 70 years old, above 75 years old, and above 80 years old were observed, separately. This benefit was also showed in lymph node-negative (N0) and lymph node-positive (N1) subgroups and N0 patients are more likely to take an advantage from surgery than N1 patients. The different outcomes between surgery and non-surgery suggest that surgical treatment may be recommended for elderly ICC if the tumor is resectable to ensure optimal treatment.

[1]  T. Pawlik,et al.  Survival Benefit of Primary Tumor Resection Among Elderly Patients with Pancreatic Neuroendocrine Tumors , 2021, World Journal of Surgery.

[2]  I. Endo,et al.  Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches. , 2020, JAMA surgery.

[3]  G. Gores,et al.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management , 2020, Nature Reviews Gastroenterology & Hepatology.

[4]  J. Ferlay,et al.  Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012 , 2020, Cancer.

[5]  H. Lang,et al.  Resection of intrahepatic cholangiocarcinoma in elderly patients – is it reasonable? , 2019, BMC Surgery.

[6]  A. Ejaz,et al.  Intrahepatic Cholangiocarcinoma. , 2019, Surgical oncology clinics of North America.

[7]  Yajin Chen,et al.  Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[8]  N. de’Angelis,et al.  Laparoscopic liver resection in elderly patients: systematic review and meta-analysis , 2019, Surgical Endoscopy.

[9]  G. Poston,et al.  Changing outlook for colorectal liver metastasis resection in the elderly. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  L. Partridge,et al.  Facing up to the global challenges of ageing , 2018, Nature.

[11]  T. Pawlik,et al.  Challenges of surgical management of intrahepatic cholangiocarcinoma , 2018, Expert review of gastroenterology & hepatology.

[12]  E. Vibert,et al.  Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma , 2018, The British journal of surgery.

[13]  G. Gores,et al.  Cholangiocarcinoma — evolving concepts and therapeutic strategies , 2018, Nature Reviews Clinical Oncology.

[14]  Natasha Azzopardi-Muscat,et al.  Demographic trends and public health in Europe. , 2017, European journal of public health.

[15]  Xinyuan Lu,et al.  Liver resection for intrahepatic cholangiocarcinoma in AJCC‑stage Ⅳ: An evaluation of the survival benefit and prognostic accuracy of current AJCC staging system on N and M classification. , 2016, Oncology reports.

[16]  Han Zhang,et al.  Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management. , 2016, Cancer letters.

[17]  Andrew X. Zhu,et al.  Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise , 2016, The oncologist.

[18]  G. Spolverato,et al.  A multi‐institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma , 2016, Journal of surgical oncology.

[19]  Lena Osterhagen,et al.  Multiple Imputation For Nonresponse In Surveys , 2016 .

[20]  David Moher,et al.  The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines , 2015, PloS one.

[21]  T. Nishidate,et al.  The impact of aging on morbidity and mortality after liver resection: a systematic review and meta-analysis , 2015, Surgery Today.

[22]  T. Hibi,et al.  Validation of Hepatectomy for Elderly Patients with Hepatocellular Carcinoma , 2015, Annals of Surgical Oncology.

[23]  H. Nakahara,et al.  Safety of hepatectomy for elderly patients with hepatocellular carcinoma. , 2014, World journal of gastroenterology.

[24]  T. Pawlik,et al.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. , 2014, Journal of hepatology.

[25]  E. Finlayson,et al.  Preoperative assessment of the older patient: a narrative review. , 2014, JAMA.

[26]  S. G. de la Fuente,et al.  Functional Status Determines Postoperative Outcomes in Elderly Patients Undergoing Hepatic Resections , 2013, Journal of surgical oncology.

[27]  M. Kendrick,et al.  Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[28]  H. El‐Serag,et al.  Risk factors for cholangiocarcinoma , 2011, Hepatology.

[29]  M. Aljiffry,et al.  Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. , 2009, Journal of the American College of Surgeons.

[30]  M. Monden,et al.  Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. , 2008, Journal of hepato-biliary-pancreatic surgery.

[31]  I. Endo,et al.  Intrahepatic cholangiocarcinoma , 2014, Radiopaedia.org.

[32]  Jasjeet S. Sekhon,et al.  Multivariate and Propensity Score Matching Software with Automated Balance Optimization: The Matching Package for R , 2008 .

[33]  M. Choti,et al.  A Proposed Staging System for Intrahepatic Cholangiocarcinoma , 2008, Annals of Surgical Oncology.

[34]  K. McGlynn,et al.  A Comparison of Trends in the Incidence of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in the United States , 2006, Cancer Epidemiology Biomarkers & Prevention.

[35]  K. McGlynn,et al.  Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.

[36]  K. McGlynn,et al.  Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? , 2004, Journal of hepatology.

[37]  H. Thomas,et al.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.

[38]  T. Patel.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[39]  M. Kemeny,et al.  Cancer surgery in the elderly. , 2000, Hematology/oncology clinics of North America.

[40]  B. Hankey,et al.  Surveillance, Epidemiology, and End Results Program , 1999 .

[41]  S. Fan,et al.  Intrahepatic Cholangiocarcinoma , 1997, World Journal of Surgery.

[42]  M. Lubin.  Is age a risk factor for surgery? , 1993, The Medical clinics of North America.

[43]  D. Mohr.  Estimation of Surgical Risk in the Elderly: A Correlative Review , 1983, Journal of the American Geriatrics Society.